The phenotype is characterized by decreased fat deposition, lower plasma concentrations of glucose, insulin and cholesterol, higher glucose tolerance and insulin sensitivity, and resistance to diet-induced obesity [12, 13]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.